Viewing Study NCT04858334


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-01-08 @ 9:42 AM
Study NCT ID: NCT04858334
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Sponsor:
Organization: